Inventor · disambiguated record
Carlos Santos
Also filed as: SANTOS CARLOS · SANTOS CARLOS F
7 granted patents·11 pending applications·24 citations·filing 2010–2022
80Inventor score
Files withAPERTA BIOSCIENCES LLC3BRODSKY ROBERT A3ACCENTIA BIOPHARMACEUTICALS INC2AFFIGEN LLC2BIOVEST INT INC2
Top patents by PatentIndex Score
18 records- 0187US9026372B2Methods for providing a system of care for a high-dose oxazaphosphorine drug regimenO'DONNELL JR FRANCIS·Filed 2010·Granted May 5, 2015·12 cites·32 claims
- 0277US10730901B2Spinosyn formulations for treatment of demodex-induced ocular and facial conditionsAPERTA BIOSCIENCES LLC·Filed 2019·Granted Aug 4, 2020·2 cites·20 claims
- 0377US9725768B2Methods for producing high-fidelity autologous idiotype vaccinesBIOVEST INT INC·Filed 2013·Granted Aug 8, 2017·3 cites·26 claims
- 0477US8673321B2Cyclophosphamide in combination with anti-idiotypic vaccinesBRODSKY ROBERT A·Filed 2011·Granted Mar 18, 2014·6 cites·26 claims
- 0560US2022378813A1Spinosyn formulations for treatment of demodex-induced ocular and facial conditionsAPERTA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 0657US11254701B2Spinosyn formulations for treatment of Demodex-induced ocular and facial conditionsAPERTA BIOSCIENCES LLC·Filed 2020·Granted Feb 22, 2022·0 cites·20 claims
- 0756US10221249B2Method of making patient specific anti-idiotype antibodiesAFFIGEN LLC·Filed 2016·Granted Mar 5, 2019·1 cites·9 claims
- 0843US2024240267A1Assays for detecting pathogensANGSTROM BIO INC·Filed 2021·Application pending·0 cites
- 0942US9279803B2Method of identifying patients not suitable for high-dose cyclophosphamide treatmentBRODSKY ROBERT A·Filed 2011·Granted Mar 8, 2016·0 cites·10 claims
- 1042US2011097426A1Methods for Safe and Effective Treatment Using Oxazaphosphorine DrugsACCENTIA BIOPHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1142US2011117050A1Methods for Providing a System of Care for an Oxazaphosphorine Drug RegimenACCENTIA BIOPHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 1241US2014363456A1Tumor-specific gm-csf cytokine response as predictor of cancer vaccine effectivenessBIOVEST INT INC·Filed 2012·Application pending·0 cites
- 1341US2012114634A1Methods for inducing a sustained immune response against a b-cell idiotype using autologous anti-idiotypic vaccinesSTERGIOU ANGELOS M·Filed 2011·Application pending·0 cites
- 1440US2012148577A1Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejectionFUCHS EPHRAIM J·Filed 2011·Application pending·0 cites
- 1538US2012128685A1Use of high-dose oxazaphosphorine drugs in combination with monoclonal antibodies for treating immune disordersBRODSKY ROBERT A·Filed 2011·Application pending·0 cites
- 1637US2014140986A1Materials and methods for directing an immune response to an epitopeSANTOS CARLOS F·Filed 2011·Application pending·0 cites
- 1735US2019292275A1Sequencing-directed selection of tumor theranosticsAFFIGEN LLC·Filed 2019·Application pending·0 cites
- 1831US2014037615A1Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignanciesSANTOS CARLOS F·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carlos Santos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →